Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide after prior alendronate or risedronate in postmenopausal osteoporosis
2004-002317-37Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of teriparatide in postmenopausal osteoporosis (2 cohorts), sponsored by Sanofi. Started Nov 2004; status: completed.
02
Drugs
teriparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2004-002317-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002317-37.